Stock Scorecard
Stock Summary for CVS Health Corp (CVS) - $95.89 as of 5/18/2026 1:25:47 PM EST
Total Score
13 out of 30
Safety Score
65 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for CVS
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CVS
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CVS
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for CVS
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for CVS (65 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 6 |
| Operating Margin (Max of 10) | 1 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 2 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for CVS
Financial Details for CVS
Company Overview |
|
|---|---|
| Ticker | CVS |
| Company Name | CVS Health Corp |
| Country | USA |
| Description | CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island. |
| Sector Name | HEALTHCARE |
| Industry Name | HEALTHCARE PLANS |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 95.89 |
| Price 4 Years Ago | 81.77 |
| Last Day Price Updated | 5/18/2026 1:25:47 PM EST |
| Last Day Volume | 8,798,380 |
| Average Daily Volume | 8,613,626 |
| 52-Week High | 98.43 |
| 52-Week Low | 57.05 |
| Last Price to 52 Week Low | 68.08% |
Valuation Measures |
|
| Trailing PE | 42.06 |
| Industry PE | 64.18 |
| Sector PE | 89.31 |
| 5-Year Average PE | 12.94 |
| Free Cash Flow Ratio | 12.82 |
| Industry Free Cash Flow Ratio | 9.85 |
| Sector Free Cash Flow Ratio | 26.04 |
| Current Ratio Most Recent Quarter | 0.87 |
| Total Cash Per Share | 7.48 |
| Book Value Per Share Most Recent Quarter | 60.84 |
| Price to Book Ratio | 1.49 |
| Industry Price to Book Ratio | 6.19 |
| Sector Price to Book Ratio | 8.57 |
| Price to Sales Ratio Twelve Trailing Months | 0.30 |
| Industry Price to Sales Ratio Twelve Trailing Months | 0.56 |
| Sector Price to Sales Ratio Twelve Trailing Months | 24.40 |
| Analyst Buy Ratings | 18 |
| Analyst Strong Buy Ratings | 7 |
Share Statistics |
|
| Total Shares Outstanding | 1,275,927,000 |
| Market Capitalization | 122,348,640,030 |
| Institutional Ownership | 89.82% |
Dividends |
|
| Ex-Dividend Date | 4/23/2026 |
| Previous Dividend Amount | 0.6650 |
| Current Dividend Amount | 0.6650 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 2.66 |
| Trailing Annual Dividend Yield | 2.74% |
| Forward Annual Dividend Rate | 2.66 |
| Forward Annual Dividend Yield | 2.74% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 3.41% |
| 5-Year Average Dividend Yield | 3.94% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 4.86% |
| All-Time Dividend Growth Rate Percentage | 6.93% |
| Dividend Payout Ratio | 116.67% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 63.10% |
| Annual Earnings Growth | -61.68% |
| Reported EPS 12 Trailing Months | 2.28 |
| Reported EPS Past Year | 2.57 |
| Reported EPS Prior Year | 6.75 |
| Net Income Twelve Trailing Months | 2,932,000,000 |
| Net Income Past Year | 1,768,000,000 |
| Net Income Prior Year | 4,614,000,000 |
| Quarterly Revenue Growth YOY | 6.10% |
| 5-Year Revenue Growth | 8.39% |
| Operating Margin Twelve Trailing Months | 4.12% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 9,542,000,000 |
| Total Cash Past Year | 8,512,000,000 |
| Total Cash Prior Year | 8,586,000,000 |
| Net Cash Position Most Recent Quarter | -50,989,000,000 |
| Net Cash Position Past Year | -51,990,000,000 |
| Long Term Debt Past Year | 60,502,000,000 |
| Long Term Debt Prior Year | 60,527,000,000 |
| Total Debt Most Recent Quarter | 60,531,000,000 |
| Equity to Debt Ratio Past Year | 0.55 |
| Equity to Debt Ratio Most Recent Quarter | 0.56 |
| Total Stockholder Equity Past Year | 75,214,000,000 |
| Total Stockholder Equity Prior Year | 75,560,000,000 |
| Total Stockholder Equity Most Recent Quarter | 77,456,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 7,394,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 5.80 |
| Free Cash Flow Past Year | 7,807,000,000 |
| Free Cash Flow Prior Year | 6,326,000,000 |
Options |
|
| Put/Call Ratio | 0.70 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.59 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 67.59 |
System |
|
| Modified | 5/18/2026 9:07:31 PM EST |